Faeth Therapeutics (FTH) Shares Outstanding (2020 - 2026)

Faeth Therapeutics (FTH) has reported Shares Outstanding (Entity) for 7 consecutive years, with $5.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 347.42% year-over-year to $5.6 million; the trailing twelve-month figure through Jun 2026 stood at $5.6 million (up 347.42% YoY), and the FY2025 full-year result was $1.3 million, down 94.99% from the prior year.
• Shares Outstanding (Entity) rose to $5.6 million in Q2 2026 per FTH's latest filing, from $1.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $31.0 million in Q1 2023 and bottomed at $1.3 million in Q2 2025.
• Historically, Shares Outstanding (Entity) has averaged $20.4 million across 5 years, with a median of $25.1 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) tumbled 94.99% in 2025, then jumped 347.42% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $30.8 million in 2022, then slipped by 18.64% to $25.0 million in 2023, then rose by 0.6% to $25.2 million in 2024, then sank by 94.99% to $1.3 million in 2025, then soared by 347.28% to $5.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $5.6 million, $1.3 million, and $1.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.